News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MANNING MARTHA E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2023 |
4
| MANNING MARTHA E (VP, GEN. COUNSEL & CORP. SEC.) has filed a Form 4 on MARINUS PHARMACEUTICALS, INC.|
Txns:
| Granted 16,548 shares
@ $0
Granted 74,468 options to buy
@ $5.94, valued at
$442.3k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| MANNING MARTHA E (VP Gen Counsel and Corp Sec.) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Granted 57,500 options to buy
@ $12.6, valued at
$724.5k
|
|
| 06/17/2020 |
4
| MANNING MARTHA E (VP, Gen. Counsel & Corp. Sec.) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Granted 300,000 options to buy
@ $2.52, valued at
$756k
|
|
| 06/17/2020 |
3
| MANNING MARTHA E (VP, Gen. Counsel & Corp. Sec.) has filed a Form 3 on MARINUS PHARMACEUTICALS INC |
| 01/29/2020 |
4
| MANNING MARTHA E (General Counsel) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 2,500 shares
@ $6.3, valued at
$15.8k
Disposed/sold 215,000 options to buy
@ $2.9, valued at
$623.5k
Disposed/sold 150,000 options to buy
@ $2.18, valued at
$327k
Disposed/sold 110,000 options to buy
@ $6.79, valued at
$746.9k
Disposed/sold 135,000 options to buy
@ $4.11, valued at
$554.9k
|
|
| 01/25/2019 |
4
| MANNING MARTHA E (General Counsel) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 150,000 options to buy
@ $2.18, valued at
$327k
|
|
| 02/13/2018 |
4
| MANNING MARTHA E (General Counsel) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 215,000 options to buy
@ $2.9, valued at
$623.5k
|
|
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|